SION
NASDAQ · Biotechnology
Sionna Therapeutics Inc
$39.87
+1.04 (+2.68%)
Open$38.40
Previous Close$38.83
Day High$42.31
Day Low$37.28
52W High$48.45
52W Low$13.81
Volume—
Avg Volume390.8K
Market Cap1.68B
P/E Ratio—
EPS$-1.92
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
-37.1% upside
Current
$39.87
$39.87
Target
$25.06
$25.06
$14.18
$25.06 avg
$26.23
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 242.99M | 245.23M | 253.21M |
| Net Income | -48,406,908 | -45,232,819 | -47,387,261 |
| Profit Margin | -19.9% | -18.5% | -18.7% |
| EBITDA | -47,660,000 | -53,758,331 | -46,826,478 |
| Free Cash Flow | -27,352,313 | -27,764,891 | -38,614,891 |
| Rev Growth | +24.0% | +24.2% | +22.9% |
| Debt/Equity | 0.34 | 0.34 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |